Abstract
Cholera toxin acts by ADP-ribosylating a membrane protein, variously termed N, G, or G/F, that is a guanine nucleotide-binding regulatory component of adenylate cyclase. Membranes of several mammalian cells contain two peptides, of Mr = 42,000 and 52,000, which are radiolabeled by incubation with cholera toxin and [32P]NAD. Toxin activation of N in avian and human erythrocytes leads to significant radiolabeling only of the Mr = 42,000 peptide. Thus ADP-ribosylation of the Mr = 42,000 peptide appears to suffice for stimulation of adenylate cyclase, and no biological function has yet been assigned to the Mr = 52,000 peptide. We have found that incubation with toxin and [32P]NAD significantly radiolabels an Mr = 52,000 peptide, but not an Mr = 42,000 peptide in particulate preparations of A9 mouse and 380-6 hamster transformed lung fibroblasts. Treatment of intact A9 or 380-6 cells with cholera toxin increases their cyclic AMP content and blocks subsequent toxin-catalyzed incorporation of 32P from NAD into the Mr = 52,000 peptide of particulate extracts from the toxin-treated cells. Treating A9 and 380-6 particulate extracts with toxin and NAD increases their N activity in the presence of GTP, assayed using N-deficient membranes of the S49 cyc- mutant. We conclude that (1) a functionally active form of the N protein can contain the Mr = 52,000 peptide and (2) ADP-ribosylation of the Mr = 52,000 peptide subunit of N can mediate the action of cholera toxin.
- Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|